8-KOther Events

QUEST DIAGNOSTICS INC 8-K Report (Aug 13, 2002)

Filed August 13, 2002For Securities:DGX

Summary

This 8-K filing from Quest Diagnostics Incorporated (DGX), dated August 12, 2002, reports on the submission of sworn statements by its Chief Executive Officer, Kenneth W. Freeman, and Chief Financial Officer, Robert A. Hagemann, to the Securities and Exchange Commission (SEC). These statements were made pursuant to SEC Order 4-460 and Section 906 of the Sarbanes-Oxley Act of 2002, which was enacted earlier that year. The Sarbanes-Oxley Act significantly increased the accountability of public companies and their executives regarding financial reporting.

Key Highlights

  • 1Quest Diagnostics filed a Form 8-K on August 12, 2002, to report a significant corporate event.
  • 2The filing confirms that the CEO and CFO submitted sworn statements to the SEC.
  • 3These statements were made in accordance with SEC Order 4-460 and Section 906 of the Sarbanes-Oxley Act of 2002.
  • 4The Sarbanes-Oxley Act of 2002 mandated increased corporate responsibility and accuracy in financial reporting.
  • 5This action indicates Quest Diagnostics' compliance with new regulatory requirements enacted shortly after the Sarbanes-Oxley Act's passage.
  • 6The filing is procedural, confirming adherence to new legal and regulatory frameworks impacting public companies.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose that Quest Diagnostics' Chief Executive Officer and Chief Financial Officer submitted sworn statements to the SEC, as required by the Sarbanes-Oxley Act of 2002 and related SEC orders.

The Sarbanes-Oxley Act of 2002 (SOX) is a landmark federal law that mandated significant reforms in corporate governance and financial disclosure. It aimed to protect investors by improving the accuracy and reliability of financial reporting by public companies, and Section 906 specifically deals with corporate responsibility for financial reports.

This filing itself does not indicate any specific financial restatements or problems. It is a procedural filing confirming compliance with new legal requirements following the passage of the Sarbanes-Oxley Act, which mandated enhanced executive accountability for financial reports.

The sworn statements were submitted by Kenneth W. Freeman, the Chief Executive Officer of Quest Diagnostics, and Robert A. Hagemann, the Chief Financial Officer of Quest Diagnostics.